One Biosciences
PrivateLast Round
Series A
Jul 17, 2025
Total Funding Raised
$30.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
One Biosciences operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in July 2025.
One Biosciences is a biotechnology company that provides an AI-driven, single-cell analysis platform for precision oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
One Biosciences Comparables
Compare One Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 1Cell.Ai | 84% | |
| Singleron Biotechnologies | 78% | |
| Predicta Biosciences | 78% |
For institutional investors. Book with your work email.
One Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 17, 2025 | ||||
| Seed | Sep 13, 2022 | ||||
| Seed | Jul 22, 2020 |
For institutional investors. Book with your work email.
One Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Seed, Series A |
| Kima Ventures | Series A |
| Blast.club | Series A |
| Adamed Technology | Series A |
| Galion.exe | Series A |
| Home Biosciences | Series A, Seed |
| Sofinnova Partners | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 1548% MoM, from 42 to 692.
- Oct 1, 2025
Partnered with Institut Curie and Gustave Roussy in France.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 28, 2026
One Biosciences received $3.7M in non-dilutive public funding from Bpifrance under the France 2030 i-Démo 5 call to finance the four-year CAST project with Institut Curie.
For institutional investors. Book with your work email.
One Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about One Biosciences's valuation, stock price, and market status.
Is One Biosciences a public or private company?
One Biosciences is a private company.
What is the current stock price of One Biosciences?
One Biosciences is a private company, so its shares have no public market price. Caplight tracks One Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is One Biosciences worth (valuation)?
Valuation information for One Biosciences is not publicly available.
Can I buy One Biosciences stock?
One Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was One Biosciences's last funding round?
One Biosciences's most recent funding round was Series A on July 17, 2025.
Who are the main investors in One Biosciences?
Key investors in One Biosciences include Redmile Group, Blast.club, Home Biosciences.
Will One Biosciences IPO soon?
No public IPO plans have been announced for One Biosciences.
How can I track One Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in One Biosciences's shares on secondary markets.